Patents

US 9334496 B2: Antisense EGFRAS guanidinium peptide nucleic acid (GPNA) oligonucleotides as antitumor agents

Granted
2016-05-10
Filed
2011-05-13 application 13107344
Type
Utility · 2 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

A class of antisense agents having a distributed guanidinium peptide nucleic acids (GPNA) backbone which has excellent uptake into mammalian cells, can bind to the target DNA or RNA in a highly sequence specific manner and can resist nucleases and proteases both outside and inside the cell(s) of interest. In one embodiment, either systemic or intratumoral administration of antisense Epidermal Growth Factor Receptor (“EGFR”) GPNA oligonucleotides is believed to downmodulate EGFR levels, thus in turn to reduce head and neck squamous cell carcinoma tumor growth, which has been confirmed to date both in vitro and in vivo.

Source: PVGPATDIS, file of 2026-04-10 (ipg160510.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
EYE & EAR FOUNDATION 1 patentsUS company or organizationPittsburgh, PAEye & Ear Foundation State business registration EXACT high confidence: identical full name and state
EYE & EAR FOUNDATION INC Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
PVGPATDIS, file of 2026-04-10
University of Pittsburgh—Of the Commonwealth System of Higher Education 1,390 patentsUS company or organizationPittsburgh, PAPVGPATDIS, file of 2026-04-10
CARNEGIE MELLON UNIVERSITY 794 patentsUS company or organizationPittsburgh, PACarnegie Mellon University College or university EXACT high confidence: identical full name and state
CARNEGIE MELLON UNIVERSITY Federal lobbying client EXACT high confidence: identical full name and state
CARNEGIE MELLON UNIVERSITY Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Jennifer Rubin GrandisPittsburgh, PA9Person page FUZZY medium confidencePVGPATDIS, file of 2026-04-10
Sufi Mary ThomasSpringdale Township, PA2PVGPATDIS, file of 2026-04-10
Danith H. LyPittsburgh, PA23PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/111PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2012-09-28Assignment
Assignment of assignor's interest
LY, DANITH H, PHD signed 2012-08-01CARNEGIE MELLON UNIVERSITY PITTSBURGH, PA29046/839ECORSEXC, file of 2026-09-25
2011-05-24Assignment
Assignment of assignor's interest
EYE & EAR FOUNDATION signed 2011-05-03UNIVERSITY OF PITTSBURGH--OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION PITTSBURGH, PA
EYE & EAR FOUNDATION PITTSBURGH, PA
26331/353ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.